Original Research
Published on 21 Nov 2025
Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III trial
in Inflammation Pharmacology
- 269 views
Original Research
Published on 21 Nov 2025
in Inflammation Pharmacology
Original Research
Published on 21 Nov 2025
in Coral Reef Research
Original Research
Published on 21 Nov 2025
in Ethnopharmacology
Original Research
Published on 21 Nov 2025
in Neurorehabilitation
Review
Published on 21 Nov 2025
in Nutrition, Psychology and Brain Health
Original Research
Published on 21 Nov 2025
in Complex Physical Systems
Original Research
Published on 21 Nov 2025
in Microbial Symbioses
Original Research
Published on 21 Nov 2025
in Translational Medicine
Mini Review
Published on 21 Nov 2025
in Cellular Neurophysiology
Technology and Code
Published on 21 Nov 2025
in RNA Bioinformatics
Editorial
Published on 21 Nov 2025
in Georeservoirs
Case Report
Published on 21 Nov 2025
in Microbial Immunology
Original Research
Published on 21 Nov 2025
in Digital Public Health
Brief Research Report
Published on 21 Nov 2025
in Brain-Computer Interfaces
Original Research
Published on 21 Nov 2025
in Public Mental Health
Systematic Review
Published on 21 Nov 2025
in Psychological Therapy and Psychosomatics